ADRIANNE WOLFE: Open Payments
NPI 1942857800 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$471 in 12 payments from 7 companies in 2025. Trend: 2023 $317 · 2024 $349 · 2025 $471
Food & beverage: $471
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $145 |
| Alkermes, Inc. | 3 | $138 |
| Novo Nordisk Inc | 1 | $117 |
| Lundbeck LLC | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: MAVYRET, VIVITROL, Ozempic, REXULTI, Qelbree, INGREZZA, UZEDY, VRAYLAR.
Industry payments across OK — which companies pay providers there.
